Corina Loghin
-
- Diabetes Treatment and Management 14
- Pharmacology top 2%
- Pharmacology and Obesity Treatment 5
- Pharmacogenetics and Drug Metabolism 4
- Endocrine and Autonomic Systems top 10%
- Physiology top 10%
-
- Metabolism, Diabetes, and Cancer 6
-
- Pancreatic function and diabetes 4
- Helicobacter pylori-related gastroenterology studies 3
-
- Gastrointestinal motility and disorders 2
-
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Shweta UrvaXuewei CuiTamer CoşkunCharles BensonDaniel A. BriereAxel HauptWilliam C. RoellKyle W. Sloop
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Corina Loghin
20 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Endocrinology, Diabetes and Metabolism 815
- Pharmacology 378
- Endocrine and Autonomic Systems 92
- Physiology 242
- Cellular and Molecular Neuroscience 162
Countries citing papers authored by Corina Loghin
This map shows the geographic impact of Corina Loghin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina Loghin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina Loghin more than expected).
Fields of papers citing papers by Corina Loghin
This network shows the impact of papers produced by Corina Loghin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina Loghin. The network helps show where Corina Loghin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Corina Loghin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of conceptbreakdown → | 2022 | 180 |
| 2 | 2021 | 41 | |
| 3 | 2021 | 7 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 4 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 92 | |
| 8 | 2020 | 1 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 2 | |
| 11 | LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of conceptbreakdown → | 2018 | 603 |
| 12 | 2017 | 17 | |
| 13 | 2015 | 75 | |
| 14 | 2015 | 1 | |
| 15 | 2015 | 46 | |
| 16 | 2012 | 11 | |
| 17 | 2011 | 0 | |
| 18 | 2008 | 35 | |
| 19 | 2005 | 7 | |
| 20 | 2004 | 82 |
About Corina Loghin
Corina Loghin is a scholar working on Endocrinology, Diabetes and Metabolism, Gastroenterology and Pharmacology, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (6 papers), Pharmacology and Obesity Treatment (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Pancreatic function and diabetes (4 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Gastrointestinal motility and disorders (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (815 citations), Pharmacology (378 citations) and Endocrine and Autonomic Systems (92 citations). Corina Loghin has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Shweta Urva, Xuewei Cui, Tamer Coşkun, Charles Benson, Daniel A. Briere, Axel Haupt, William C. Roell, Kyle W. Sloop, Ruth E. Gimeno and Julie S. Moyers. Their work appears in journals such as Circulation, Cell Metabolism and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.